Skip to main content
. 2022 Jan 3;75:103802. doi: 10.1016/j.ebiom.2021.103802

Figure 1.

Figure 1

Biomarker development pathway. Biomarkers were selected via a multi-stage process using up to four independent sample sets. MS, mass spectrometry; PDAC, pancreatic cancer; CP, chronic pancreatitis; LSDM, long-standing diabetes (>3yr post-diagnosis of DM); NOD, new-onset diabetes (<3 yr post-diagnosis of DM).